Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Couper

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Chest|November 17, 2022
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPDSpyridon Fortis, Pedro M Quibrera, Alejandro P Comellas, et al.
Chest|February 4, 2021
Ratio of FEV<sub>1</sub>/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
Plos Genetics|April 15, 2011
Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumptionMarilyn C Cornelis, Keri L Monda, Kai Yu, et al.
BMJ Open Respiratory Research|December 19, 2025
Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota linksShuo Cao, Abhishek Shrivastav, Eugene R Bleecker, et al.
American Journal of Respiratory and Critical Care Medicine|November 12, 2020
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in SmokersEleanor M Dunican, Brett M Elicker, Travis Henry, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
Journal of the American Heart Association|March 30, 2013
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortiumAlvaro Alonso, Bouwe P Krijthe, Thor Aspelund, et al.
Circulation. Cardiovascular Genetics|April 20, 2010
Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortiumAlanna C Morrison, Janine F Felix, L Adrienne Cupples, et al.
Respiratory Research|April 28, 2021
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPDKatherine A Pratte, Jeffrey L Curtis, Katerina Kechris, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Chest|November 17, 2022
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPDSpyridon Fortis, Pedro M Quibrera, Alejandro P Comellas, et al.
Chest|February 4, 2021
Ratio of FEV<sub>1</sub>/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung FunctionSpyridon Fortis, Alejandro P Comellas, Surya P Bhatt, et al.
Plos Genetics|April 15, 2011
Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumptionMarilyn C Cornelis, Keri L Monda, Kai Yu, et al.
BMJ Open Respiratory Research|December 19, 2025
Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota linksShuo Cao, Abhishek Shrivastav, Eugene R Bleecker, et al.
American Journal of Respiratory and Critical Care Medicine|November 12, 2020
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in SmokersEleanor M Dunican, Brett M Elicker, Travis Henry, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary DiseaseKristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort AnalysisIgor Z Barjaktarevic, Russell G Buhr, Xiaoyan Wang, et al.
Journal of the American Heart Association|March 30, 2013
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortiumAlvaro Alonso, Bouwe P Krijthe, Thor Aspelund, et al.
Circulation. Cardiovascular Genetics|April 20, 2010
Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortiumAlanna C Morrison, Janine F Felix, L Adrienne Cupples, et al.
Respiratory Research|April 28, 2021
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPDKatherine A Pratte, Jeffrey L Curtis, Katerina Kechris, et al.
Pageof 20